BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Biotech Bay

  Personalis Reels in $33 Million

  January 13, 2015

   · 

  1 min read
• Policy

  After Public Shaming in 2013, 23andMe Aims to End FDA Standoff

  January 13, 2015

   · 

  1 min read
• Policy

  FDA Waiver Of Alere Inc.'s Flu Test Poses Threat to Cepheid

  January 13, 2015

   · 

  1 min read
• Drug Development

  Celsus Therapeutics Completes Enrollment Of Phase 2 Trial Of MRX-6 Cream 2% In Pediatric Atopic Dermatitis

  January 13, 2015

   · 

  3 min read
• Policy

  Evofem, Inc. Announces Pre-NDA Meeting With FDA For Amphora®

  January 13, 2015

   · 

  1 min read
• Drug Development

  BioMarin Provides Preliminary Data From Ongoing Phase 1/2 Pivotal Study Of BMN 190 For Treatment Of CLN2 Disorder, A Form Of Batten Disease

  January 13, 2015

   · 

  7 min read
• Business

  Therapix And Dekel Pharmaceuticals Sign Binding Term Sheet Outlining Licensing And Royalty Agreement

  January 13, 2015

   · 

  2 min read
• Genetown

  Aldeyra Therapeutics Announces $7.79 Million Private Placement

  January 13, 2015

   · 

  5 min read
• ProSensa Holding N.V. Announces Shareholder Approval Of Certain Matters Relating To The BioMarin Tender Offer

  January 13, 2015

   · 

  5 min read
• Drug Development

  Capricor Therapeutics, Inc. Initiates The DYNAMIC Clinical Trial For The Treatment Of Advanced Heart Failure

  January 13, 2015

   · 

  5 min read